Ravi K Murthy Selected Research

ecotropic murine leukemia virus receptor

1/2004

Identification of an extracellular domain within the human PiT2 receptor that is required for amphotropic murine leukemia virus binding.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ravi K Murthy Research Topics

Disease

8	Macular Degeneration (Age-Related Maculopathy) 06/2014 - 07/2010
4	Retinal Detachment (Retinal Detachments) 01/2015 - 01/2009
3	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2015 - 08/2009
3	Ganglion Cysts (Ganglion) 09/2013 - 06/2008
2	Neoplasms (Cancer) 01/2013 - 01/2009
2	Retinal Perforations 09/2012 - 05/2010
2	Macular Edema 01/2012 - 01/2010
2	Cataract (Cataracts) 08/2009 - 06/2008
1	Ischemia 11/2014
1	Neovascular Glaucoma 11/2014
1	Wet Macular Degeneration 01/2014
1	Sickle Cell Anemia (Hemoglobin S Disease) 11/2013
1	Pulmonary Arterial Hypertension 11/2013
1	Retinal Artery Occlusion 11/2013
1	Choroidal Neovascularization 09/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Necrosis 06/2011
1	Retinal Diseases 01/2011
1	Retinal Vein Occlusion 01/2011
1	Pathologic Neovascularization 09/2010
1	Hemangioma (Angioma) 09/2009
1	Pain (Aches) 08/2009
1	Retinal Neovascularization 04/2009
1	Corneal Neovascularization 04/2009
1	Atrophy 01/2009
1	Glaucoma 06/2008
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 06/2008
1	Infections 01/2004

Drug/Important Bio-Agent (IBA)

8	Retinaldehyde (Retinal)IBA 11/2015 - 01/2009
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014 - 04/2009
3	Bevacizumab (Avastin)FDA Link 01/2014 - 04/2009
2	Coloring Agents (Dyes)IBA 11/2014 - 06/2011
2	Retinal Pigments (Pigments, Visual)IBA 09/2013 - 06/2011
1	Messenger RNA (mRNA)IBA 11/2014
1	LuteinIBA 06/2014
1	ZeaxanthinsIBA 06/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	CytokinesIBA 01/2014
1	Tadalafil (Cialis)FDA Link 11/2013
1	Phosphodiesterase 5 InhibitorsIBA 11/2013
1	CobaltIBA 09/2013
1	Protons (Proton)IBA 09/2013
1	EnzymesIBA 01/2013
1	ResveratrolIBA 01/2013
1	ImmunosorbentsIBA 01/2013
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2013
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	Neuroprotective AgentsIBA 09/2010
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 07/2010
1	Indicators and Reagents (Reagents)IBA 05/2010
1	Triamcinolone (Aristocort)FDA Link 01/2010
1	SolutionsIBA 08/2009
1	Lidocaine (Xylocaine)FDA LinkGeneric 08/2009
1	Tetracaine (Amethocaine)FDA LinkGeneric 08/2009
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 08/2009
1	Nerve Growth Factor (NGF)IBA 06/2008
1	ecotropic murine leukemia virus receptorIBA 01/2004
1	gibbon ape leukemia virus receptorIBA 01/2004

Therapy/Procedure

3	Vitrectomy 01/2015 - 01/2010
3	Therapeutics 01/2013 - 04/2009
2	Phacoemulsification 01/2015 - 08/2009
2	Light Coagulation 11/2014 - 01/2012
2	Lasers (Laser) 09/2012 - 01/2012
1	Proton Therapy 03/2012
1	Intravitreal Injections 01/2011
1	Scleral Buckling 01/2010
1	Photochemotherapy (Photodynamic Therapy) 09/2009
1	Anesthesia 08/2009
1	Corneal Transplantation (Keratoplasty) 04/2009
1	Drug Therapy (Chemotherapy) 01/2009